Breakout Sessions II
Take a deeper dive into the topics that matter most to your organization. These interactive sessions are designed to share targeted insights and encourage collaborative discussions.
Building Community Trust & Engagement For Trial Enrollment
The strongest recruitment pipelines are built on something that no vendor can sell: genuine community trust. Sites that invest in community relationships — through local health networks, cultural partnerships, faith-based organizations, and consistent community presence — consistently outperform those that rely on advertising alone. Hear how LATAM sites are building and sustaining meaningful community engagement strategies that expand patient awareness, increase enrollment, and create long-term goodwill that serves your site across every study.
Country Roundtable — Mexico, Colombia, Peru
Mexico, Colombia, and Peru represent three of Latin America’s most compelling growth markets in clinical research. Mexico and Colombia share large, diverse, and largely treatment-naïve populations with high patient motivation, and both have regulatory bodies — COFEPRIS and INVIMA, respectively — actively modernizing to reduce approval timelines and increase predictability. Peru adds a distinct dimension: a highly diverse patient population, a steadily strengthening regulatory authority in DIGEMID, and growing Phase 2–3 opportunity that is placing the country on sponsor shortlists as a high-value complement to more established markets. Together, these countries represent a reform-driven, population-rich corridor with significant upside for sites positioned to capitalize on it.
Patient Recruitment Strategies In Competitive Markets
Patient recruitment is the heartbeat of every successful clinical trial, and the sites that master it have a lasting competitive advantage. As more sites across Latin America compete for eligible participants, the differentiator is not just outreach volume but strategy: community relationships, referral networks, digital tools, and a deep understanding of what moves patients from awareness to enrollment. This session shares what is working across LATAM markets and equips sites to build a recruitment infrastructure that delivers consistently across studies, therapeutic areas, and sponsor relationships.
Regulatory Landscape: Momentum & Opportunities Across LATAM
Latin America’s regulatory environment is evolving — and for well-prepared sites, that evolution represents opportunity. Significant reforms in Argentina, Brazil, Mexico, and other countries are reshaping approval timelines, multi-country execution, and the region’s overall competitiveness as a research destination. This session provides a current overview of where the regulatory landscape exists across key markets, what the data shows about real-world timeline improvements, and how sites can use this momentum to their advantage.